propidium has been researched along with gyki 52466 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldberg, MP; Tekkök, SB | 1 |
Kristensen, BW; Noraberg, J; Zimmer, J | 1 |
2 other study(ies) available for propidium and gyki 52466
Article | Year |
---|---|
Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Axons; Benzodiazepines; Calcium; Cell Death; Cell Hypoxia; Corpus Callosum; Excitatory Amino Acid Antagonists; Female; Glucose; Hypoxia, Brain; In Vitro Techniques; Mice; Models, Biological; Nerve Fibers, Myelinated; Oligodendroglia; Oxygen; Propidium; Quinoxalines; Receptors, AMPA; Sodium Channel Blockers | 2001 |
Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Dizocilpine Maleate; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Isoxazoles; Kainic Acid; Microtubule-Associated Proteins; N-Methylaspartate; Neuroprotective Agents; Neurotoxins; Nissl Bodies; Nuclear Proteins; Propidium; Propionates; Quinoxalines; Rats; Rats, Wistar | 2001 |